This Changes Things hosts Baker Machado and Hope King break down the biggest stories in business, technology, and retail. Macy's reported stronger than expected earnings, capitalizing on its real estate assets. Plus, why Amazon's Alexa may be in the doghouse for some brands.
Macy's earnings beat analysts' expectations signaling its turnaround may be gaining traction. Same-store sales were up 3% in January and the company sees that momentum continuing through 2018.
Plus, big consumer brands are not very happy with Amazon's Alexa. The growing popularity of voice search assistants is posing a threat to the biggest makers of household items...already dealing with the rise of e-commerce. Unlike in stores and on online, where brands get plenty of exposure, voice search assistants often direct shoppers to a single product...usually selected by an algorithm without any input from the sellers.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
